Status: Recruiting
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
The primary objective of this study is to assess the effect of enobosarm on total body weight
Participants needed: 200
Trial details
Phase: Phase 2Age: 65-100Biological sex: AllType: InterventionalSponsor: Veru Inc.Updated: Jul 1, 2026Locations: 14
Eligibility criteria
Provide informed consent from the subject or the subject's legally authorized re... [+7]
Known hypersensitivity or allergy to enobosarm or a GLP-1 receptor agonist [+27]